High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group

Autor:	Ingo G.H. Schmidt-Wolf, Michael Pfreundschuh, Gabriele Ihorst, Elke Valk, Kristina Fritsch, Mascha Binder, Agnieszka Korfel, Alexander Röth, Juergen Finke, Heidi Fricker, Gerald Illerhaus, Ulrich Keller, Gertlinde Egerer, Elisabeth Schorb, Robert Möhle, Monika Lamprecht, L. von Baumgarten, Johannes Bloehdorn, Benjamin Kasenda, Roland Schroers
Rok vydání:	2017
Předmět:	Adult Male Oncology Cancer Research medicine.medical_specialty Lymphoma medicine.medical_treatment Medizin ThioTEPA Transplantation Autologous Central Nervous System Neoplasms 03 medical and health sciences 0302 clinical medicine Autologous stem-cell transplantation Recurrence hemic and lymphatic diseases Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Prospective Studies Aged Chemotherapy Carmustine business.industry Hematopoietic Stem Cell Transplantation Primary central nervous system lymphoma Brain Hematology Middle Aged medicine.disease Combined Modality Therapy Surgery Transplantation Treatment Outcome Drug Resistance Neoplasm 030220 oncology & carcinogenesis Retreatment Cytarabine Female Rituximab business 030215 immunology medicine.drug
Zdroj:	Leukemia. 31:2623-2629
ISSN:	1476-5551 0887-6924
DOI:	10.1038/leu.2017.170
Popis:	To investigate safety and efficacy of high-dose chemotherapy followed by autologous stem cell transplantation (HCT-ASCT) in relapsed/refractory (r/r) primary central nervous system lymphoma (PCNSL), we conducted a single-arm multicentre study for immunocompetent patients (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc670e7af48dacb20c283eccedfd8688 https://doi.org/10.1038/leu.2017.170 Zobrazit plný text záznamu Full text from SpringerLink